MCI 176

Known as: 4(3H)-Quinazolinone, 2-((2,5-dimethoxyphenyl)methyl)-3-(2-(dimethylamino)ethyl)-6-(1-methylethoxy)-, monohydrochloride, MCI-176 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1999
0119861999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Purpose. A theoretical study was performed to generate a pharmacophore model for chemically diverse structures that specifically… (More)
Is this relevant?
1991
1991
The effect of 2-(2,5-dimethoxyphenylmethyl)-3-(2-dimethylaminoethyl)- 6-isopropoxy-4(3H)-quinazolinone hydrochloride (MCI-176), a… (More)
Is this relevant?
1989
1989
MCI-176, a new calcium channel blocker, increases coronary blood flow and may improve perfusion in ischaemic areas. Its… (More)
Is this relevant?
1988
1988
Effects of MCI-176, 2-(2,5-dimethoxyphenylmethyl)-3-(2-dimethylaminoethyl)-6-isopro pox y-4(3H)- quinazolinone hydrochloride, on… (More)
Is this relevant?
1987
1987
We compared the coronary vasodilator and cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in isolated, blood… (More)
Is this relevant?
1987
1987
Calcium antagonistic activity of MCI-176, a new calcium antagonist, was compared with those of diltiazem and nifedipine in… (More)
Is this relevant?
Review
1987
Review
1987
Calcium antagonists constitute a group of organic compounds with diverse chemical structures. Although their main pharmacodynamic… (More)
Is this relevant?
1986
1986
Effects of MCI-176, 2-(2,5-dimethoxyphenylmethyl)-3-(2-dimethylaminoethyl)-6-isopropox y-4 (3H)-quinazolinone hydrochloride, on… (More)
Is this relevant?